Discover
AKTX
Akari Therapeutics, Plc
10.25
1 x 11.11
1 x 10.78
bid
ask
+
0.01
0.05%
1 @ 04:08 AM
9.94 -0.31 (3.02%)
| Ytd | -11.33% | |
| 1y | -78.00% |
10.20
day range
11.86
3.02
52 week range
49.60
| Open | 10.29 | Prev Close | 10.24 | Low | 10.20 | High | 11.86 | Mkt Cap | 17.94M |
| Vol | 38.88K | Avg Vol | 799.56K | EPS | N/A | P/E | N/A | Forward P/E | -0.29 |
| Beta | 0.95 | Short Ratio | 1.92 | Inst. Own | 0.51% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-22 | 50-d Avg | 9.73 | 200-d Avg | 15.16 | 1yr Est | 80.00 |
| Income Statement | |||
| Operating Expenses | 15.76M | ||
| Research and Development Expense | 1.46M | ||
| Selling, General and Administrative Expense | 2.17M | ||
| Operating Income | -15.76M | ||
| Interest Expense | 61.00K | ||
| Income Tax Expense | -859.00K | ||
| Net Income | -14.45M | ||
| Net Income Common Stock | -14.45M | ||
| Net Income Common Stock (USD) | -14.45M | ||
| Consolidated Income | -14.45M | ||
| Earning Before Interest & Taxes (EBIT) | -15.25M | ||
| Earning Before Interest & Taxes (USD) | -15.25M | ||
| Weighted Average Shares | 118.76B | ||
| Weighted Average Shares Diluted | 118.76B | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.83M | ||
| Cash and Equivalents (USD) | 2.83M | ||
| Current Assets | 3.59M | ||
| Total Assets | 33.89M | ||
| Debt Current | 732.00K | ||
| Total Debt | 732.00K | ||
| Current Liabilities | 13.42M | ||
| Total Liabilities | 19.51M | ||
| Accumulated Retained Earnings (Deficit) | -279.00M | ||
| Accumulated Other Comprehensive Income | -768.00K | ||
| Shareholders Equity | 14.38M | ||
| Shareholders Equity (USD) | 14.38M | ||
| Assets Non-Current | 30.30M | ||
| Total Debt (USD) | 732.00K | ||
| Goodwill and Intangible Assets | 30.30M | ||
| Liabilities Non-Current | 6.09M | ||
| Trade and Non-Trade Payables | 8.64M | ||
| Tax Liabilities | 6.09M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 53.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.43M | ||
| Issuance (Purchase) of Equity Shares | 188.00K | ||
| Issuance (Repayment) of Debt Securities | -135.00K | ||
| Net Cash Flow from Operations | -2.49M | ||
| Share Based Compensation | 305.00K | ||